| Univariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|---|
Variable | No. of Patients (n = 83) | Median OS | P-Value | Hazard Ratio * | P-Value |
Methods |  |  |  < 0.001 |  | 0.001 |
 DEB-TACE | 42 | 12.0 (8.7–15.3) |  | 1 |  |
 C-TACE | 41 | 5.0 (3.8–6.2) |  | 2.4 (1.4–4.1) |  |
Child–Pugh |  |  | 0.663 |  |  |
 A | 66 | 7.0 (3.8–10.1) |  |  |  |
 B | 17 | 9.0 (1.7–16.3) |  |  |  |
AFP value | Â | Â | 0.297 | Â | Â |
 ≤ 400 | 37 | 9.0 (5.5–12.5) |  |  |  |
 > 400 | 46 | 6.0 (4.2–7.8) |  |  |  |
APS |  |  |  < 0.001 |  | 0.019 |
 Present | 34 | 4.0 (2.7–5.3) |  | 1.9 (1.1–3.2) |  |
 Absent | 49 | 12.0 (9.6–14.4) |  | 1 |  |
HVI | Â | Â | 0.133 | Â | Â |
 Present | 55 | 5.0 (3.0–7.0) |  |  |  |
 Absent | 28 | 10.0 (5.8–14.2) |  |  |  |
EHS | Â | Â | 0.831 | Â | Â |
 Present | 26 | 5.0 (0.3–9.7) |  |  |  |
 Absent | 57 | 8.0 (5.1–10.9) |  |  |  |
Maximum Diameter | Â | Â | 0.086 | Â | 0.456 |
 ≤ 5 cm | 18 | 12.0 (5.0–19.0) |  |  |  |
 > 5 cm | 65 | 6.0 (3.8–8.2) |  |  |  |
Capsular Infiltration | Â | Â | 0.001 | Â | 0.015 |
 Non-infiltration | 33 | 12.0 (9.1–14.9) |  | 1 |  |
 Infiltration | 50 | 5.0 (3.5–6.5) |  | 1.9 (1.1–3.3) |  |
Tumor Numbers | Â | Â | 0.533 | Â | Â |
 Single | 17 | 13.0 (0.0–28.2) |  |  |  |
 Multiple | 66 | 8.0 (5.6–10.4) |  |  |  |
DCR |  |  |  < 0.001 |  |  < 0.001 |
 CR + PR + SD | 54 | 12.0 (9.3–14.7) |  | 1 |  |
 PD | 29 | 4.0 (3.4–4.6) |  | 4.0 (2.2–7.3) |  |
Follow-up TKI | Â | Â | 0.155 | Â | Â |
 Yes | 30 | 9.0 (5.4–12.6) |  |  |  |
 No | 53 | 5.0 (3.0–7.0) |  |  |  |